Publication: Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand
Issued Date
1999-01-01
Resource Type
ISSN
00029637
Other identifier(s)
2-s2.0-0032922705
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Tropical Medicine and Hygiene. Vol.60, No.1 (1999), 14-21
Suggested Citation
A. Brockman, R. E.L. Paul, T. J.C. Anderson, I. Hackford, L. Phaiphun, S. Looareesuwan, F. Nosten, K. P. Day Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. American Journal of Tropical Medicine and Hygiene. Vol.60, No.1 (1999), 14-21. doi:10.4269/ajtmh.1999.60.14 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/25462
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand
Other Contributor(s)
Abstract
Parasite genotyping by the polymerase chain reaction was used to distinguish recrudescent from newly acquired Plasmodium falciparum infections in a Karen population resident on the northwestern border of Thailand where malaria transmission is low (one infection/person/year). Plasmodium falciparum infections were genotyped for allelic variation in three polymorphic antigen loci, merozoite surface proteins-1 and -2 (MSP-1 and -2) and glutamate-rich protein (GLURP), before and after antimalarial drug treatment. Population genotype frequencies were measured to provide the baseline information to calculate the probability of a new infection with a different or the same genotype to the initial pretreatment isolate. Overall, 38% of the infections detected following treatment had an identical genotype before and up to 121 days after treatment. These post-treatment genotypes were considered recrudescent because of the low (≤ 5%) probability of repeated occurrence by chance in the same patient. This approach allows studies of antimalarial drug treatment to be conducted in areas of low transmission since recrudescences can be distinguished confidently from newly acquired infections.